Form 10 Explorer
10-Q
Quarterly Report
VITASPRING BIOMEDICAL CO., LTD.

CIK: 1697884

File #: 333-216645

Period End: Oct 31, 2024

Fiscal Year: 2025

View on EDGAR
Balance Sheet
28 line items · 2 periods
XBRL
ItemOct 31, 2024Jan 31, 2024
BALANCE SHEETS
ASSETS
CURRENT ASSETS
Cash
2,06213
Other Non-Operating Current Assets
39,7250
Other Current Assets
023,614
Total current assets
41,78723,627
LONG-TERM ASSETS
Property, Plant and Equipment
16,59524,063
Operating Lease Right-of-Use Asset
089,652
Total long-term assets
16,595113,715
Total assets
58,382137,342
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts Payable
2,411,0002,411,000
Other Non-Operating Current Liabilities
445,951339,001
Taxes Payable
297,079218,714
Operating Lease Liability, Current
093,334
Advances from related party
776,415425,482
Total current liabilities
3,930,4453,487,531
Total liabilities
3,930,4453,487,531
COMMITMENTS AND CONTINGENCIES
00
STOCKHOLDERS' DEFICIT
Total Stockholders' Equity
20,70320,703
Total Stockholders' Equity
1,245,6001,135,689
Total Stockholders' Equity
(5,138,366)(4,506,581)
Total stockholders' deficit
(3,872,063)(3,350,189)
Total liabilities and stockholders' deficit
58,382137,342